V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10404569 | 10041033 | 1.69 | 54.6 | Palliative (P) | 2018-02-20 | 2018-02-20 | BCG Intravesical | 02 | null | CISPLATIN + VINORELBINE | 100843959 |
| 10404684 | 10041035 | 1.6 | 58.8 | Adjuvant (A) | 2019-09-27 | 2019-10-09 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | CISPLATIN + VINORELBINE | 101708601 |
| 10404687 | 10041036 | 1.78 | 78.6 | Adjuvant (A) | 2017-05-28 | 2017-05-28 | CHOP R | 02 | null | CHOP R | 100317824 |
| 10404770 | 10041037 | null | 95.6 | Neo-adjuvant (N) | 2019-01-08 | 2019-01-08 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 101667419 |
| 10404847 | 10041038 | 1.72 | 63.6 | Neo-adjuvant (N) | 2018-08-14 | 2018-09-12 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101674111 |
| 10405013 | 10041039 | 1.78 | 67.5 | Curative (C) | 2022-03-24 | 2022-03-28 | Sunitinib | 02 | N | CISPLATIN + FLUOROURACIL | 100859205 |
| 10405042 | 10041040 | 1.75 | 82.1 | Palliative (P) | 2017-09-30 | 2017-10-01 | Capecitabine + Cisplatin | 02 | Y | CYCLOPHOSPHAMIDE + DOCETAXEL | 101692462 |
| 10405141 | 10041041 | 1.68 | 0 | Palliative (P) | 2019-03-24 | 2019-03-27 | null | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101737220 |
| 10405190 | 10041042 | 1.78 | 84 | Palliative (P) | 2017-10-15 | 2017-11-11 | TEMOZOLOMIDE | 02 | N | TEMOZOLOMIDE | 100121130 |
| 10405281 | 10041044 | 1.73 | 101 | Curative (C) | 2022-05-20 | 2022-05-21 | null | 02 | null | POMALIDOMIDE | 100271645 |
| 10405555 | 10041047 | 1.68 | 71 | null | 2017-04-11 | 2017-04-25 | Cytarabine Low Dose | 02 | null | DABRAFENIB + TRAMETINIB | 101650779 |
| 10405611 | 10041048 | null | null | 03 | 2017-02-21 | 2017-03-19 | Venetoclax | 02 | N | CISPLATIN + FLUOROURACIL | 100690085 |
| 10405721 | 10041051 | 1.68 | 80.2 | null | 2017-07-05 | 2017-07-10 | Venetoclax | 02 | null | VENETOCLAX | 101440671 |
| 10405760 | 10041052 | 1.72 | 67.15 | Adjuvant (A) | 2021-03-14 | 2021-04-03 | R GCVP | Y | N | BUSULFAN | 100170053 |
| 10405823 | 10041053 | 1.7 | 88 | Palliative (P) | 2020-03-25 | 2020-04-05 | Avelumab | 02 | N | AVELUMAB | 101016992 |
| 10405908 | 10041054 | 1.75 | 93.7 | Palliative (P) | 2018-04-13 | 2018-04-29 | Cisplatin +Fluorouracil (3 wk) | 02 | N | DABRAFENIB + TRAMETINIB | 101012876 |
| 10405960 | 10041055 | 1.62 | 89.9 | Palliative (P) | 2017-09-30 | 2017-10-07 | Avelumab | 02 | N | AVELUMAB | 101636181 |
| 10405970 | 10041056 | 1.56 | 79 | null | 2022-03-16 | 2022-04-04 | Trial Unspecified | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100177787 |
| 10405992 | 10041057 | 1.88 | 121 | Curative (C) | 2018-06-27 | 2018-07-16 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | SUNITINIB | 101791626 |
| 10406018 | 10041058 | 0 | 0 | Palliative (P) | 2018-04-27 | 2019-01-13 | Palbociclib | 02 | N | PALBOCICLIB | 100181934 |
| 10406034 | 10041059 | 0 | 100.2 | Palliative (P) | 2019-08-14 | 2019-08-19 | Palbociclib | 02 | N | PALBOCICLIB | 100435760 |
| 10406162 | 10041060 | 1.62 | 73.2 | 03 | 2019-07-28 | 2019-08-13 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100415871 |
| 10406306 | 10041061 | 1.52 | 70.9 | Adjuvant (A) | 2019-11-21 | 2019-11-22 | Venetoclax | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101444411 |
| 10406321 | 10041062 | 1.51 | 0.1 | null | 2018-07-01 | 2018-07-08 | Trial Unspecified | 02 | N | BCG | 101299104 |
| 10406408 | 10041063 | 1.68 | 64 | 02 | 2020-07-17 | 2020-07-24 | POMALIDOMIDE | Y | N | CVP R | 101720633 |
| 10406460 | 10041064 | 1.56 | 86.6 | null | 2019-04-17 | 2019-04-18 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100537496 |
| 10406635 | 10041069 | null | 75 | Adjuvant (A) | 2017-07-04 | 2017-07-05 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100702599 |
| 10406810 | 10041071 | 1.68 | 60.8 | Palliative (P) | 2018-06-28 | 2018-06-29 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101632854 |
| 10407005 | 10041072 | 1.74 | null | Adjuvant (A) | 2020-02-04 | 2020-02-18 | CHOP - 21 days | 02 | N | CISPLATIN + VINORELBINE | 101455723 |
| 10407064 | 10041073 | 1.64 | 82.6 | Curative (C) | 2018-06-24 | 2019-08-23 | FEC 100 + DOCETAXEL | 02 | null | BUSULFAN | 100531099 |
| 10407552 | 10041077 | 1.52 | 121 | Palliative (P) | 2018-05-04 | 2018-05-17 | Venetoclax | 02 | N | VENETOCLAX | 101427462 |
| 10407575 | 10041078 | 0 | 0 | null | 2019-10-11 | 2019-10-15 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100380477 |
| 10407673 | 10041079 | null | 65 | Palliative (P) | 2017-07-03 | 2017-07-08 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101636867 |
| 10407830 | 10041080 | 1.81 | 83 | Palliative (P) | 2017-04-15 | 2017-05-01 | Palbociclib | 02 | N | PALBOCICLIB | 100920085 |
| 10407838 | 10041081 | 1.58 | 69.5 | null | 2022-01-06 | 2022-01-06 | CHOP R - 21 days | 02 | null | CHOP R | 101651126 |
| 10407842 | 10041082 | 1.52 | 92.7 | null | 2019-07-24 | 2019-07-29 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101361428 |
| 10408073 | 10041085 | 0 | 0 | 03 | 2019-02-06 | 2019-02-17 | Folfirinox | 02 | N | MITOMYCIN | 100427610 |
| 10408096 | 10041086 | null | null | Curative (C) | 2017-10-03 | 2017-10-23 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100259832 |
| 10408247 | 10041088 | 1.72 | 59.9 | Curative (C) | 2018-05-26 | 2018-06-20 | Cisplatin +Fluorouracil (3 wk) | 02 | N | MITOMYCIN | 100286432 |
| 10408403 | 10041089 | 1.78 | 67 | null | 2019-12-15 | 2019-12-18 | Cisplatin + Fluorouracil + RT 5day | 02 | null | VENETOCLAX | 101029680 |
| 10408442 | 10041091 | 1.5 | 85.3 | Palliative (P) | null | 2020-07-17 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100540929 |
| 10408485 | 10041092 | 1.78 | 78 | null | 2019-10-24 | 2019-10-24 | CISPLATIN + FLUOROURACIL | 02 | null | CYTARABINE | 100999271 |
| 10408496 | 10041093 | 1.63 | 101.4 | Palliative (P) | 2019-06-28 | 2019-07-11 | BCG Intravesical | 02 | null | MITOMYCIN | 101250182 |
| 10408511 | 10041094 | 1.84 | 80 | Palliative (P) | 2016-12-26 | 2016-12-26 | MITOMYCIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101107522 |
| 10408520 | 10041095 | 1.76 | 94 | 03 | 2015-06-11 | 2015-06-11 | CHOP - 21 days | N | N | CISPLATIN + FLUOROURACIL | 100744273 |
| 10408574 | 10041097 | 1.46 | 57.4 | Palliative (P) | 2018-07-09 | 2018-07-27 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 1 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100688459 |
| 10408584 | 10041098 | 1.66 | 65.6 | Palliative (P) | 2019-05-30 | 2019-06-01 | Cisplatin + Fluorouracil + RT 5day | N | N | DARATUMUMAB | 101185546 |
| 10408649 | 10041099 | 1.75 | 72.6 | null | 2019-09-15 | 2019-09-17 | Fluorouracil + Folinic Acid Weekly | 02 | null | FLUOROURACIL | 101620380 |
| 10408658 | 10041100 | 0 | 70 | null | 2019-07-17 | 2019-07-23 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 101204875 |
| 10408859 | 10041102 | 1.71 | 48 | null | 2018-12-01 | 2018-12-30 | DARATUMUMAB | 02 | null | CVP R | 100178184 |